These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30641210)

  • 21. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
    Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
    Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians.
    Fawzy MS; Elfayoumi AR; Mohamed RH; Fatah IRA; Saadawy SF
    Biochem Genet; 2016 Jun; 54(3):326-336. PubMed ID: 26920155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
    Safarinejad MR; Shafiei N; Safarinejad S
    Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
    Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
    Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.
    Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
    Asian Pac J Cancer Prev; 2010; 11(2):365-70. PubMed ID: 20843117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of SNPs/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population.
    Bandil K; Singhal P; Dogra A; Rawal SK; Doval DC; Varshney AK; Bharadwaj M
    Inflamm Res; 2017 Dec; 66(12):1085-1097. PubMed ID: 28993831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
    Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Hsu PC; Chen CC; Yang YC; Shih HY; Chin YT; Pei JS; Chang WS; Tsai CW; Kuo CC; Bau DT
    Anticancer Res; 2023 Dec; 43(12):5359-5366. PubMed ID: 38030180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population.
    Taheri M; Pouresmaeili F; Omrani MD; Habibi M; Sarrafzadeh S; Noroozi R; Rakhshan A; Sayad A; Ghafouri-Fard S
    Biomark Med; 2017 May; 11(5):413-422. PubMed ID: 28621612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of LTβR gene polymorphisms with prostate volume in benign prostatic hyperplasia in the Korean population.
    Lee SH; Kim SK; Yoo KH; Chung JH; Chang SG
    Genet Mol Res; 2015 Dec; 14(4):18607-15. PubMed ID: 26782510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA POLR2E gene polymorphisms increased the risk of prostate cancer in a sample of the Iranian population.
    Sattarifard H; Hashemi M; Hassanzarei S; Basiri A; Narouie B; Ghavami S
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(1):1-11. PubMed ID: 30587086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
    Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between interleukin 8 -251 A/T and +781 C/T polymorphisms and osteoarthritis risk.
    He Y; Liang X; Wu X; Meng C; Wu B; Fu D; Jin S; Yang S; Wang H
    Immunol Lett; 2014 Nov; 162(1 Pt A):207-11. PubMed ID: 25194757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between tumor necrosis factor-alpha gene rs1800629 (-308G/A) and rs361525 (-238G > A) polymorphisms and prostate cancer risk in an Iranian cohort.
    Alidoost S; Habibi M; Noormohammadi Z; Hosseini J; Azargashb E; Pouresmaeili F
    Hum Antibodies; 2020; 28(1):65-74. PubMed ID: 31594215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
    Mandal RK; Gangwar R; Mandhani A; Mittal RD
    DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia.
    Tsuchiya N; Wang L; Horikawa Y; Inoue T; Kakinuma H; Matsuura S; Sato K; Ogawa O; Kato T; Habuchi T
    Int J Oncol; 2005 Jan; 26(1):225-31. PubMed ID: 15586244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.
    Habibi M; Mirfakhraie R; Khani M; Rakhshan A; Azargashb E; Pouresmaeili F
    Gene; 2017 Nov; 634():47-52. PubMed ID: 28882566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
    Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK
    Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
    Li Z; Habuchi T; Mitsumori K; Kamoto T; Kinoshitu H; Segawa T; Ogawa O; Kato T
    J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.